June 30, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
AGA’s recent white paper provides a framework to navigate the latest innovations in obesity care, including GLP-1 receptor agonists, personalized treatment plans and endoscopic, bariatric and metabolic therapies.The new commentary is a follow up to AGA’s 2017 publication, “POWER: Practice Guide on Obesity and Weight Management, Education, and Resources,” and encourages
June 30, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CMS goes live with GLP-1 Bridge program for Part D beneficiaries

First Stop Health expands weight management program, shares first-year results

With Medicare's GLP-1 'bridge' coming soon, Walmart expands weight management supports for consumers

Lifestyle intervention remains a core component of obesity management, alongside the emergence of more potent pharmacotherapy.The…

SAN DIEGO — GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand…

The latest obesity drug updates, research and clinical insights, from GLP-1 receptor agonists to new drugs in the pipeline.

ACP has published living clinical guidance to help physicians select medications for patients with overweight or…

Obesity is a chronic disease. This statement is clearly at the heart of the answer to this question. When you look at the data in…

A digital weight management program reduced “food noise” for adults with obesity, with greater benefits observed among adults…